doi:10.3390/toxins2092289 Babiker A, Alawi A, Al Atawi M, Al Alwan I
For instance, some individuals report that injecting before bedtime might reduce daytime nausea, though this is anecdotal and not evidence-based
Injectable Semaglutide has not been evaluated by the FDA, but side effects are expected to be similar to other Semaglutide-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)
Starting a week before stimulation is mostly symbolic
placebo in the PIONEER 6 trial